Cervical myelomeningocele--follow-up of five patients

Andreas D Meyer-Heim1, Andrea Klein, Eugen Boltshauser

  • 1Division of Paediatric Neurology, University Children's Hospital, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland.

Insights

Cervical myelomeningocele (cMMC) and cervical meningocele (cMC) outcomes are favorable for neurological and urological issues. However, prevention with folic acid is crucial due to high costs and potential spinal cord dysfunction.

Area of Science:

  • Neurology
  • Pediatric Surgery
  • Public Health

Background:

  • Few patient series on cervical myelomeningocele (cMMC) and cervical meningocele (cMC) exist.
  • Outcomes and interventions for these rare spinal defects are not well-documented.

Purpose of the Study:

  • To analyze interventions and outcomes (neurologic, orthopedic, urologic, intellectual) in patients with cMMC and cMC.
  • To highlight the importance of folic acid prevention and regular follow-up for spinal cord dysfunction.

Main Methods:

  • Retrospective analysis of five patients diagnosed between 1984-1999.
  • Review of interventions, neurologic status, orthopedic function, urologic continence, and cognitive abilities.
  • Average follow-up duration of 9.5 years.

Main Results:

  • All patients achieved independent ambulation and urinary continence.
  • Neurologic deficits included hemiparesis and arm paresis in some.
  • Cognitive functions were age-appropriate in two, with three requiring special education.
  • Associated conditions included Chiari II malformation and hydrocephalus.
  • Tethering of the cervical cord was observed in three patients.

Conclusions:

  • Outcomes for cMMC are generally favorable compared to lower neural tube defects.
  • High costs and the need for ongoing care emphasize the importance of folic acid prevention.
  • Regular neurologic and urodynamic evaluations are vital to monitor for spinal cord tethering or re-tethering.

Related Concept Videos